. Correction to: Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial. Clin Infect Dis 2023 Jan 6:ciac970. doi: 10.1093.
PMID: 36617223